Esperance Pharmaceuticals, Inc — Form D/A
Esperance Pharmaceuticals, Inc of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2010-05-03. The offering totals $9.0M, of which $9.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-05-03
- Form: D/A
- Accession: 0001451464-10-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $9.0M
- Amount sold: $9.0M
- Investors: 3
- Date of first sale: 2006-10-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-124766
Issuer
- Name: Esperance Pharmaceuticals, Inc
- CIK: 0001451464
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: TWO HOUSTON CENTER, HOUSTON, TX, 77010
- Phone: 713-276-7600
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Richard Babb | Executive Officer | Hammond, LA |
| Ross Barrett | Director | Shreveport, LA |
| Chad Souvignier | Director | Hayward, CA |
| Hector Alila | Director | Houston, TX |
| Hector Alila | Executive Officer | Houston, TX |
| Joseph Lovett | Director | Houston, TX |
| Peter Hoang | Director | Houston, TX |
| Sonia Deggs | Executive Officer | Houston, TX |
| Carola Leuschner | Executive Officer | Houston, TX |
Other filings by this issuer (3)
More